HOME > ARCHIVE
ARCHIVE
- OTC NEWS IN BRIEF
November 17, 2003
- Daiichi: Cravit, Artist Contribute to Good Sales
November 17, 2003
- Soiken to Develop Biomarkers for Fatigue
November 17, 2003
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
November 17, 2003
- Drugstore Chains Using Weather Derivatives to Avoid Risk
November 17, 2003
- Basic Policy for Next NHI Pricing Reform Proposed to Chuikyo Subcommittee
November 17, 2003
- Banyu Presents 1st Report on Its Large Japanese Study on Nu-Lotan
November 17, 2003
- NEW PRODUCTS
November 17, 2003
- MRA Effective against Adult RA, JIA: Chugai
November 17, 2003
- BULLETIN
November 17, 2003
- SEMIANNUAL BUSINESS RESULTS
November 17, 2003
- BUSINESS NEWS IN BRIEF
November 17, 2003
- Press Seminar
November 17, 2003
- Industry Polarization Became Marked in the Last Decade
November 17, 2003
- MEDICAL DEVICE NEWS IN BRIEF
November 17, 2003
- Taiyo Pharmaceutical: Sales Up 46.0%, Ordinary Profits Up 86.0%
November 17, 2003
- Chuikyo Subcommittee to Review Pricing of Insurance-covered Medical Materials
November 17, 2003
- JT: Pharma Division Sales Down 4.3%
November 17, 2003
- JCQHC Warns Against High-concentration K Preparations, 10% Xylocaine
November 17, 2003
- Kyorin: Sales Down 3.3% due to Decline in Sales of Gatiflo
November 17, 2003
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
